| Literature DB >> 24473721 |
Manoela Fávaro Francisconi, José Fernando Castanha Henriques, Guilherme Janson, Karina Maria Salvatore de Freitas, Patrícia Bittencourt Dutra dos Santos.
Abstract
OBJECTIVE: This prospective study assessed the stability of Class II treatment with the Bionator, followed by fixed appliances, 10 years after treatment.Entities:
Mesh:
Year: 2013 PMID: 24473721 PMCID: PMC3891279 DOI: 10.1590/1679-775720130002
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Mean, standard deviation (SD), minimum and maximum values of the ages at T1, T2 and T3 and of the treatment with the Bionator, fixed appliance, and both (T1-T2) and long-term posttreatment (T2-T3) periods
|
|
|
|
| |
| T1 age | 11.74 | 9.92 | 14.42 | 1.30 |
| T2 age | 15.38 | 13.00 | 19.50 | 1.69 |
| T3 age | 24.99 | 18.83 | 32.92 | 3.37 |
| Bionator period | 1.52 | 0.41 | 3.08 | 0.79 |
| Fixed Appliance period | 1.76 | 0.56 | 4.45 | 0.94 |
| T1-T2 period | 3.55 | 1.08 | 7.33 | 2.14 |
| T2-T3 period | 9.91 | 5.00 | 17.42 | 3.66 |
Figure 1Balters' Bionator with coverage of the mandibular incisors
Definitions of abbreviations of unusual cephalometric variables used[12,18,24,28]
| LAFH (mm)- Linear distance between ANS and Me points (ANS anterior nasal spine, Me menton point). |
| S-Go (mm)- Linear distance between S and Go points (S sella point, Go gonion point). |
| 1-NA (mm)- Linear distance between the most anterior point of maxillary central incisor and the NA line. |
| 1.NA (º)- Angle formed by the maxillary incisor long axis and the NA line. |
| 1-NB (mm)- Linear distance between the most anterior point of mandibular central incisor and the NB line. |
| 1.NB (º)- Angle formed by the mandibular incisor long axis and the NB line. |
| Nasolabial angle (º)- Angle formed by the Prn'-Sn line and UL-Sn' line (Prn' pronasal point, Sn subnasal point, UL upper lip). |
Figure 3Cephalometric variables: 1) LAFH; 2) S-Go; 3) 1-NA; 4) 1.NA; 5) 1-NB; 6) 1.NB; 7) Nasolabial angle
Comparison of the cephalometric variables at the three stages (repeated measures ANOVA followed by Tukey tests)
|
|
|
|
|
|
|
|
|
| ||
| Maxillary Skeletal Component | ||||
| SNA (º) | 82.59 (2.75)A | 81.63 (2.74)A | 82.10 (3.43)A | 0.180 |
| Co-A (mm) | 81.51 (4.26)A | 82.83 (5.40)A | 86.05 (4.10)B | 0.000 |
| Mandibular Skeletal Component | ||||
| SNB (º) | 76.85 (3.24)A | 78.63 (3.20)B | 79.16 (3.88)B | 0.000 |
| Co-Gn (mm) | 99.64 (4.79)A | 107.81 (6.75)B | 112.07 (6.32)C | 0.000 |
| Maxillomandibular Relationship | ||||
| ANB (º) | 5.68 (2.72)A | 3.01 (2.42)B | 2.93 (2.73)B | 0.000 |
| Facial Pattern | ||||
| SN.GoGn (º) | 30.52 (4.89)A | 30.47 (6.47)A | 28.43 (6.96)B | 0.008 |
| Vertical Component | ||||
| LAFH (mm) | 58.32 (4.72)A | 62.92 (5.09)B | 64.70 (6.28)C | 0.000 |
| S-Go (mm) | 66.55 (4.94)A | 73.27 (6.58)B | 77.20 (7.77)C | 0.000 |
| Maxillary Dentoalveolar Component | ||||
| 1-NA (mm) | 5.41 (2.76)A | 4.96 (2.74)A | 5.04 (2.95)A | 0.706 |
| 1.NA (º) | 31.94 (6.04)A | 27.68 (6.56)B | 26.84 (7.14)B | 0.000* |
| Mandibular Dentoalveolar Component | ||||
| 1-NB (mm) | 3.37 (2.40)A | 5.53 (2.46)B | 5.00 (2.38)B | 0.000* |
| 1.NB (º) | 26.40 (5.66)A | 31.06 (5.71)B | 29.16 (5.83)AB | 0.002 |
| Dental Relationships | ||||
| Molar Rel. (mm) | 1.17 (1.93)A | -3.27 (0.61)B | -2.95 (0.46)B | 0.000 |
| Overjet (mm) | 8.61 (2.34)A | 3.22 (0.70)B | 3.80 (1.17)B | 0.000* |
| Overbite (mm) | 4.17 (1.84)A | 2.27 (0.97)B | 2.78 (1.10)B | 0.000 |
| Soft tissue Component | ||||
| Nasolabial angle (º) | 109.79 (9.45)A | 112.01 (11.92)A | 110. 06 (10.42)A | 0.523 |
Significant at P<0.05; SD= Standard Seviation
Comparison of the occlusal statuses at the three stages (repeated measures ANOVA followed by Tukey tests)
|
|
|
|
|
|
|
|
|
| ||
| PAR | 30.13 (5.90)A | 5.39 (3.39)B | 5.60 (4.55)B | 0.000 |
Significant at P<0.05; SD= Standard Seviation
Results of the peer assessment rating (PAR) index changes during treatment and during the long-term posttreatment period
|
|
|
|
| IPAR - FPAR | 24.73 | 6.64 |
| long-term PAR - FPAR | 0.21 | 2.62 |
| Percentage of PAR treatment changes | 81.78% | 11.26 |
| Percentage of PAR long-term posttreatment changes | 4.90% | 12.26 |
PAR= peer assessment rating; SD= Standard Deviation